Now Available At Lucent Aesthetic
Worried about signs of aging but hesitant to try dermal fillers or concerned about looking too "overdone"? If you're considering BOTOX but want to explore other options, there's now an exciting alternative with longer-lasting, natural-looking results. Developed by Revance Therapeutics, the makers of RHA, DAXXIFY is an FDA-approved injectable designed to treat moderate-to-severe glabellar lines, commonly known as frown lines or "11" lines. If you're seeking a solution to smooth facial lines and wrinkles with extended results, DAXXIFY could be an excellent choice for you.
|
What are the benefits of DAXXIFY®?
DAXXIFY’s innovative peptide technology offers a potential edge over other wrinkle treatments, as it may extend the duration of results by two months or more for many patients, when compared to other injectables. It also tends to work faster than other wrinkle relaxers(Dysport 3-7 days, & Botox can take up to 10day), with DAXXIFY you can expect visible effects in as little as one day, and typically within two days. If you're seeking a treatment that delivers. quick, long-lasting results, DAXXIFY® could be the right choice for you. We've tried it ourselves here at Lucent Aesthetic & love it!!!
How Is DAXXIFY® Different??
Unlike dermal fillers, DAXXIFY doesn’t work by filling in wrinkles and fine lines. Instead, it functions similarly to BOTOX, using an FDA-approved drug called daxibotulinumtoxinA-lanm to temporarily reduce muscle activity. Specifically, it blocks certain nerve signals that cause muscles to contract. When injected into the face, DAXXIFY relaxes the overactive muscles responsible for deep wrinkles, resulting in a smoother, more refreshed appearance around the eyes, nose, and forehead.
|
What sets DAXXIFY apart is its longer-lasting results compared to BOTOX. This is due to its unique formulation, which binds the neurotoxin to a protein, extending its effect on the treated muscles. Results can typically last between 4 to 6 months.
Additionally, DAXXIFY is the first injectable neurotoxin to use a novel peptide as a stabilizer, meaning it contains no human or animal byproducts.
Additionally, DAXXIFY is the first injectable neurotoxin to use a novel peptide as a stabilizer, meaning it contains no human or animal byproducts.